arrow
K

Kamil Drucis

Medical University of Gdańsk
H指数:10
被引数:3,440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Correlation between the drainage time in dynamic indocyanine green lymphography (ICG) and axillary lymph nodes metastatic involvement in breast cancer patients—a prospective study

更正:动态吲哚菁绿淋巴造影(ICG)中的引流时间与乳腺癌患者腋窝淋巴结转移性受累的关联——一项前瞻性研究

2026-07-290
PRE
Three-year estimate of overall survival in COMBI-v, a randomized phase 3 study evaluating first-line dabrafenib (D) plus trametinib (T) in patients (pts) with unresectable or metastatic BRAF V600E/K-mutant cutaneous melanoma
2016-10-0134
OAAI
COMBI-v: health-related quality of life (HRQoL) impact of the combination of dabrafenib and trametinib (D plus T) vs vemurafenib (V) in patients with BRAF V600 metastatic melanoma (MM)
2015-09-010
PREAI
Two year estimate of overall survival in COMBI-v, a randomized, open-label, phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (Vem) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanoma
2015-09-0142
PREAI
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

达拉非尼和曲美替尼联合改善黑色素瘤的总生存率

2015-01-012.2K
OAAI